Shilpa Medicare Ltd Analyst Rating
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 2 analysts offering long term price targets for Shilpa Medicare Ltd. An average target of ₹1095.5
Source: S&P Global Market Intelligence
Shilpa Medicare Ltd Share analysis
Shilpa Medicare Ltd price forecast by 2 analysts
Upside of24.47%
High
₹1300
Target
₹1095.50
Low
₹891
Shilpa Medicare Ltd target price ₹1095.5, a slight upside of 24.47% compared to current price of ₹936. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Shilpa Medicare Ltd revenue growth forecast
Expected growth rate Q1, FY2026:54.85%
Forecast
Actual
Including amortisation and stock based compensations
Shilpa Medicare Ltd EPS growth forecast
EPS estimate Q1, FY2026:217.60%
Forecast
Actual
Source: S&P Global Market Intelligence
Shilpa Medicare Ltd Performance
Day's Low
Day's High
₹864.45₹94552 Week's Low
52 Week's High
₹313.15₹959.5
| Returns % | |
| 1 Month Return | + 5.93 % |
| 3 Month Return | + 26.48 % |
| 1 Year Return | + 135.08 % |
| Market Stats | |
| Previous Close | ₹880.15 |
| Open | ₹880.05 |
| Volume | 11.53L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹8,607.07Cr |
Shilpa Medicare Ltd Key Statistics
| P/E Ratio | 132.55 |
| PEG Ratio | 16.57 |
| Market Cap | ₹8,607.07 Cr |
| P/B Ratio | 1.87 |
| EPS | 3.68 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 1.59 |
Shilpa Medicare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹8,607.07 Cr | 37.88% | 0.53 | ₹31 Cr | ₹1,151 Cr | |
| HOLD | ₹32,572.86 Cr | 131.85% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹18,008.87 Cr | 29.69% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹6,359.97 Cr | 4.48% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹16,029.93 Cr | 50.12% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Shilpa Medicare Ltd Mutual Fund Holdings
About Shilpa Medicare Ltd
Share Price: ₹936.00 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹8,607.07Cr as of today
Revenue: ₹343.80Cr as on September 2024 (Q3 24)
Net Profit: ₹17.94Cr as on September 2024 (Q3 24)
Listing date: 03 Dec, 2009
Chairperson Name: Omprakash Inani
| Organisation | Shilpa Medicare Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Shilpa Medicare Ltd
Shilpa Medicare Gains on European Regulatory Approvals - 19 Nov, 2024
Shilpa Medicare shares rose after its subsidiary secured Certificates of Suitability from EDQM for Octreotide and Nifedipine, reflecting strong financial growth and quality commitment.
Shilpa Medicare Secures European Approval for Octreotide - 18 Nov, 2024
Shilpa Medicare's subsidiary, Shilpa Pharma Lifesciences, has obtained a Certificate of Suitability from the European Directorate for octreotide, a key active pharmaceutical ingredient, marking a significant addition to its peptide portfolio.
Shilpa Medicare Reports Impressive Q2 Profit Growth - 14 Nov, 2024
Shilpa Medicare's Q2 FY25 results show a remarkable net profit increase of over 11 times to Rs 17.94 crore, alongside significant revenue growth. The stock surged nearly 6% following the announcement, reflecting strong investor confidence.
Shilpa Medicare Faces FDA Observations, Stock Declines - 31 Oct, 2024
Shilpa Medicare's stock fell 1.33% after the US FDA issued four procedural observations following an inspection of its Bengaluru facility. The company plans to respond promptly. Despite this, Shilpa reported a significant increase in Q1 FY25 net profit and revenue.
Insights on Shilpa Medicare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 14.06 Cr → 17.94 Cr (in ₹), with an average increase of 21.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, SHILPAMED stock has moved up by 79.0%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SHILPAMED has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 5.03% to 5.09% in Sep 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 9.08% to 9.58% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 288.7 Cr → 348.79 Cr (in ₹), with an average increase of 6.0% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 68.4%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 38.92% to 37.90% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 44.39% to 44.33% in Sep 2024 quarter
Shilpa Medicare Ltd Financials
Index Inclusions
Shilpa Medicare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.33% | ||
| Foreign Institutions | 9.58% | 5.53 | |
| Mutual Funds | 5.09% | 1.24 | |
| Retail Investors | 37.9% | ||
| Others | 3.1% | 19.89 |
Shilpa Medicare Ltd Key Indicators
Shilpa Medicare Ltd Valuation
Shilpa Medicare Ltd in the last 5 years
Lowest (-6579.29x)
March 28, 2024
Industry (54.42x)
November 19, 2024
Today (132.55x)
November 19, 2024
Highest (503.73x)
February 21, 2023
Shilpa Medicare Ltd Earnings and Dividends
Shilpa Medicare Ltd Earnings Results
Shilpa Medicare Ltd’s net profit jumped 1014.29% since last year same period to ₹17.94Cr in the Q2 2024-2025. On a quarterly growth basis, Shilpa Medicare Ltd has generated 27.6% jump in its net profits since last 3-months.
Read More about Earnings ResultsShilpa Medicare Ltd Dividends May,2022
In the quarter ending March 2022, Shilpa Medicare Ltd has declared dividend of ₹1.10 - translating a dividend yield of 0.24%.
Read More about Dividends
Shilpa Medicare Ltd Technicals Summary
Bearish
Neutral
Bullish
Shilpa Medicare Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Shilpa Medicare Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Shilpa Medicare Ltd shares.
Shilpa Medicare Ltd (SHILPAMED) share price today is ₹936
Shilpa Medicare Ltd is listed on NSE
Shilpa Medicare Ltd is listed on BSE
- Today’s highest price of Shilpa Medicare Ltd is ₹945.
- Today’s lowest price of Shilpa Medicare Ltd is ₹864.45.
PE Ratio of Shilpa Medicare Ltd is 132.55
PE ratio = Shilpa Medicare Ltd Market price per share / Shilpa Medicare Ltd Earnings per share
Today’s traded volume of Shilpa Medicare Ltd(SHILPAMED) is 11.53L.
Today’s market capitalisation of Shilpa Medicare Ltd(SHILPAMED) is ₹8607.07Cr.
| Shilpa Medicare Ltd(SHILPAMED | Price |
|---|---|
52 Week High | ₹959.5 |
52 Week Low | ₹313.15 |
Shilpa Medicare Ltd(SHILPAMED) share price is ₹936. It is down -2.45% from its 52 Week High price of ₹959.5
Shilpa Medicare Ltd(SHILPAMED) share price is ₹936. It is up 198.90% from its 52 Week Low price of ₹313.15
| Shilpa Medicare Ltd(SHILPAMED | Returns |
|---|---|
1 Day Returns | 55.85% |
1 Month Returns | 5.93% |
3 Month Returns | 26.48% |
1 Year Returns | 135.08% |